Pay in 4 interest-free payments of $6.49 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
A dual incretin research peptide is a synthetic compound that activates both GLP-1R and GIPR simultaneously
The default is once daily, continuous
PubMed laboratory research record [PMID: 39990872] PubMed record related to this compound for laboratory literature review
It tells your pancreas to release insulin, signals your brain to reduce appetite, and slows the rate at which food leaves your stomach (gastric emptying)
The newest injectable option targets both GLP-1 and GIP pathways, making it more powerful than single-pathway treatments
How GLP-1s for weight loss really work GLP-1s like semaglutide might not have been intended as weight-loss drugs, but they are on track to be game changers for obesity management
US$ 29.29
US$ 29.24
US$ 22.45
US$ 24.18
US$ 23.34
US$ 24.56
